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ABSTRACT
Improving the health status of people with chronic kidney disease (CKD) through physical activity (PA) or exercise
interventions is challenging. One of the gaps in the process of translating the general public PA activity guidelines as well as
the CKD-specific guidelines into routine clinical practice is the lack of systematic recording and monitoring of PA and
physical function attributes, which can also be used to develop individualized and measurable plans of action to promote
PA for health. We aim to present an overview of key considerations for PA, physical function and health-related quality of
life (HRQoL) evaluation in people with CKD, with the aim of encouraging health professionals to integrate assessment of
these outcomes in routine practices. Physical inactivity and impaired physical function, sometimes to the extent of physical
and social disability levels, and subsequently lower perceived HRQoL, are highly prevalent in this population. Enhanced PA
is associated with better physical function that also translates into multiple health benefits. Breaking the vicious circle of
inactivity and physical dysfunction as early as possible in the disease trajectory may confer huge benefits and enhanced life
satisfaction in the longer term. With this in mind, the importance of PA/exercise interventions in CKD to improve HRQoL is
also summarized.
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PHYSICAL INACTIVITY HAS AN IMPORTANT
NEGATIVE IMPACT FOR PATIENTS
Physical activity (PA) is any body movement produced by
muscles that results in increased energy expenditure. Exercise
is a subset of PA that is planned, structured, repetitive and pur-
poseful. PA is a generic term, of which exercise is the major
component [1]. The PA level is lower in chronic kidney disease
(CKD) patients at any stage compared with healthy counter-
parts [2]. Both peritoneal dialysis (PD) and haemodialysis (HD)
patients have been found to be sedentary, with HD patients
having fewer steps measured by a pedometer, with half of the
steps on HD days compared with PD patients [3]. A study
reported that the duration of PA of HD patients per day was
42.7 min and the number of steps was <3950 [4, 5]. Another
study showed how sedentary HD patients are, showing that
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patients were in a sitting or reclining posture 73.7 6 12.9% of
the day, so almost 18 h/day [6, 7].
Several studies have found associations between the
amount of PA and survival in patients on HD. One study found
superior survival in patients with greater PA time [4]. Similarly,
another study concluded that mortality risk was lower for
regular (1 time/week) versus non-regular (<1 time/week) exer-
cisers [8]. Hishii et al. [7] found that sedentary behaviour (rela-
tive time that subjects were in a sitting or reclining posture
according to accelerometer data) was an important factor for
all-cause mortality, especially as measured over the total days
or the non-dialysis days (dialysis is per se a treatment that
requires a sitting or reclining posture).
Literature also supports that PA has a positive impact on
health-related quality of life (HRQoL). The number of steps
measured with a pedometer presented a significant inverse
correlation with the level of distress caused by one’s per-
ceived bodily dysfunction, and distress was significantly
higher in patients with lower PA [5]. Hishii et al. [6, 7] found
that patient’s sedentary behaviour was negatively associated
with HRQoL and that there was a clinical impact of sedentary
behaviour on HRQoL even after adjusting for confounding fac-
tors such as sex, duration of HD, age and history of diabetes
mellitus.
It seems that the PA level also has an impact on physical
function measured through physical performance tests (PPTs),
as a study showed that patients on HD or PD with impaired PA
measured through the adjusted activity score (AAS) of the
Human Activity Profile (HAP) scale (<53 points) had worse phys-
ical function (walking capacity measured with the 6-min walk-
ing test, gait speed in 4 m, sit-to-stand-to-sit capacity,
functional mobility as measured through the short physical
performance battery) compared with patients who were
moderately active or active (53–94 points) [9].
WHAT MEASUREMENT TOOLS TO
MEASURE PHYSICAL ACTIVITY?
The literature describes different methods of measuring PA. A
measurement tool used to measure patients’ habitual PA is the
uniaxial accelerometer [4]. An accelerometer is a device that
obtains objective information on PA patterns as it can continu-
ously measure the intensity, duration and frequency of activi-
ties. The vector magnitude in the vertical direction is divided
into different grades of 0, 0.5 or 1–9, with each grade reflecting
the intensity of the PA. Grades 1–9 represent activities ranging
from gentle walking to running [4]. Other articles have mea-
sured activity with a three-dimensional accelerometer and data
were expressed as a net vector magnitude of the acceleration in
the three axes. The vector’s magnitude was summed up over
7 days and expressed as a daily average (arbitrary units) [2, 10].
Hishii et al. [6, 7] reported that participants wore the device for
2 weeks and they defined sedentary behaviour as energy expen-
diture at 1.5 metabolic equivalents (METs) in a sitting or reclin-
ing posture.
Another PA measurement tool is the pedometer, which was
used from 6 or 7 days [3, 5, 11] to 1 month [12] in dialysis
patients to measure the mean number of steps per day.
Self-reported PA is another method. PA questionnaires are
commonly used to assess activity in the general population, as
they are inexpensive and simple to administer, and to promote
PA in HD patients, a simple and effective questionnaire is
greatly needed [5]. In patients on dialysis, questionnaires are
correlated with accelerometry (gold standard) and therefore are
valid tools to measure PA level [10]. Three questionnaires were
chosen in a validity study because they had been previously val-
idated among older persons or persons with CKD and could be
completed in 20 min. The Standford 7-day PA Recall (PAR)
Questionnaire is a self-reported questionnaire that collects in-
formation about the time spent performing various levels of ac-
tivity during the previous 7 days [13]. A MET value is assigned to
sleep and four levels of PA (light, moderate, hard and very hard).
Caloric expenditure is estimated from the MET values and PA
estimated with this instrument is reported as kcal/kg/day. The
PA Scale for the Elderly (PASE) is designed to measure activity
during the previous week based on the participants’ responses
to a series of questions [14]. The HAP [15] is a self-administered
scale designed to survey participation in common physical ac-
tivities across a broad range of energy requirements. It com-
prises a list of 94 daily activities, with the AAS being more
commonly used to report PA level. The AAS classifies patients
as having an impaired PA level (<53 points), moderately active
(53–74 points) or active (>74 points). The HAP correlated better
than the PASE with accelerometry [10]. One study found that in
Stage 3–5 CKD (patients with end-stage renal disease on HD),
the AAS correlated better than accelerometry with physical per-
formance [2].
The International PA Questionnaire (IPAQ) score is converted
to a MET (min/day of PA). A recent study reported the validity of
the IPAQ-Chinese version (IPAQ-C; short version with nine
items) by correlating results with pedometry data [5]. The
authors found a moderate correlation between the data, but
when stratified by sex, the correlation was only found for male
patients.
As a single tool, we would recommend the HAP (AAS) for di-
alysis patients, as it is inexpensive and simple to administer
and it has proved to discriminate patients with worse physical
function [9].
HOW MUCH PHYSICAL ACTIVITY?
The literature reports how much PA is suggested for patients, as
measured by different tools. A prospective observational study
followed a sample of 202 Japanese HD patients for 7 years. A
multivariable analysis was performed to estimate the indepen-
dent prognostic effect of PA time (analysed through accelerome-
try) on survival after adjustment for confounders (age,
comorbidity, among others). Patients were categorized into two
PA groups by a PA cut-off value of 50 min/day, since this value
predicted whether the HD patients could reach the gait speed
obtained by healthy counterparts [4]. They concluded that
younger age and a lower comorbidity score were found in more
active patients and they found superior survival in patients
with 50 min of PA time per day. Regarding the pedometer,
Cobo et al. [3] considered sedentary those with <5000 steps/day
as a general threshold applicable to the adult population, so the
recommendation for patients on dialysis treatment would be to
walk above this threshold. Another easy approach is to measure
PA through a self-administered questionnaire on physical exer-
cise frequency, answering the question ‘How often do you exer-
cise or do physical activity during your leisure time?’. The
recommended answer would be to exercise at least once a
week, since a study reported that mortality risk was lower for
‘regular’ (1 time/week) versus ‘non-regular’ (<1 time/week or
never) exercisers [8]. This study also concluded that mortality
risk tended to decrease as exercise frequency increased (1 time/
week versus 6–7 times/week). Regarding the HAP (AAS), the
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threshold for any patient undertaking dialysis treatment would
be to reach at least 53 points (moderately active) [9], since a re-
cent cross-sectional study showed that patients with <53 points
showed impaired functional capacity as measured with com-
monly used physical function tests.
Table 1 summarizes the main measurement tools and the
minimal amount of PA reported and the time frame reported in
the literature. These suggestions must be taken cautiously and
future meta-analysis from randomized controlled trials (RCTs)
is needed to validate them.
The above suggestions include different tools that could be
used to measure PA according to the literature. Questionnaires
are simple and cheap, and devices are objective measures. A
single measurement is enough to report the PA level.
ASSESSMENT OF PHYSICAL FUNCTION FOR
PEOPLE WITH CKD
A framework for physical function assessment
According to the World Health Organization, health is defined
as not just the absence of disease, but the harmonious balance
between physical, mental and social dimensions of life. The
physical aspect of health can be characterized and assessed by
‘symptoms’ experienced, such as pain, fatigue, breathlessness
and stiffness, and by ‘physical function indicators’, such as level
of participation in PA and one’s perceived ability or measured
capacity in carrying out various physical tasks ranging from
self-care [activities of daily living (ADL)] to more challenging
and vigorous activities that require increasing degrees of mobil-
ity, balance, strength or endurance. An adequate level of
physical function is therefore essential for independent living.
This applies to all people but becomes even more important in
people with CKD, in whom the effects of underlying disease
pathophysiology, accelerated ageing and physical inactivity fre-
quently result in levels of impairment, functional limitations
and/or disability that negatively impact on all aspects of life and
ultimately survival [17].
In the interests of standardizing physical function-related
research and practice, we recommend the adoption of
the International Classification Framework of Functioning,
Disability and Health’s classifications and terminology for
the description of physical functioning [18]. This approach
advocates that physical function assessments should be
‘grouped’ (and reported) according to their ability to describe
physiological impairment at the level of body structures and
functions (often achieved in relation to physical function via
exercise tolerance testing); function limitations of the
individual at the level of activities and primarily described
via objective PPTs and disability (participation) experiences
of the individual within their sociocultural and environmen-
tal context (largely via self-reported functional status
assessments).
Most researchers and health practitioners who manage peo-
ple with CKD would agree that no matter what domain/dimen-
sion of physical function one measures, the overall consensus
is the same: physical dysfunction and inactivity are severe and
prevalent in all ages and CKD stages compared with normative
data. Deterioration of physical function starts early in the dis-
ease process [19] and may result in the rapid onset of severe
physical frailty and disability, especially in the elderly CKD
Stage 5 population [20].
Physical function indicators are increasingly recognized as a
key characteristic of the clinical picture and life profile of CKD
sufferers and have been shown to be strong determinants of
clinically important but also patient-relevant outcomes of mor-
tality [17], morbidity, hospitalizations and life participation
(https://songinitiative.org/projects/). Yet physical function as-
sessment does not form part of the routine clinical monitoring
and evaluation of people with CKD. That this situation persists
in 2020 is surprising, as we believe a case already exists for the
regular assessment and promotion of physically active lifestyles
to enhance clinical management of the CKD patient [21, 22].
Therefore the utility of physical function assessment in CKD
can be summarized as follows:
i. people with CKD Stages 3–5 with better scores in measures
of physiological impairment [maximal oxygen consumption
(VO2max), muscle strength], functional limitations (gait
speed, sit-to-stand performance, PA levels) and in patient-
reported disability outcomes (ADL) are characterized by lon-
ger event-free survival, better mental health, less frequent
hospitalizations and fewer functional limitations. A VO2max
>17.5 mL/kg/min predicted significantly longer survival over
3.5 years. Gait speed >1.3 m/s was associated with an 18–
26% reduced risk of rapid kidney function decline in CKD
Stages 2–4. Poor timed up and go performance was associ-
ated with a 7-fold increased likelihood of ADL disability in
elderly CKD Stage 5 patients. Walking 5–6 times/week re-
duced the risk of death or dialysis by 50% over a year in CKD
Stages 2–4. Physical frailty was associated with a 2.5 times
increased risk of death or dialysis in middle-aged people with
CKD Stages 2–4. A patient-reported physical function com-
posite score (PCS) from the 36-item ShortForm Health Survey
(SF-36) questionnaire indicated that a 1-point increase corre-
sponded to a 2% reduction in mortality rate, whereas patients
Table 1. Indicative suggestions for PA amount and measurement tools
Measurement tools Time frame Minimal amount
Diaries/self reports
Self-report questionnaires
HAP average activity score [9] One single session 53 points
PASE [10, 14] One single session 103 (64.1) SD
IPAQ-C total PA [5] One single session 2154 per minute
PAR [16] One single session 38.4 (5.8) SD
Frequency of exercise or PA [8] One single session Once a week
Devices
Accelerometer uniaxial or 3D [2, 7] 1–2 weeks 50 min of PA/day
Pedometer [3, 11, 12] 6–30 days 5000 steps/day
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with an SF-36 PCS<25 had a 93% increased risk of dying and
a 56% increased risk of hospitalization [23, 24];
ii. physical function outcomes are responsive to subclinical
changes in underlying altered physiological processes
(e.g. poor nutritional status, frailty and muscle wasting,
which sometimes are hard to accurately assess) and thera-
peutic interventions such as exercise rehabilitation or life-
style behaviour changes. Appropriately designed and
implemented PA programmes can induce clinically mean-
ingful improvements in some physical function outcomes
(VO2max, PCS from the SF-36 and related questionnaires
and gait speed and distance walked) [24–26], suggesting
that routine evaluation of physical function can be used not
only as a means to characterize prognosis and adverse clini-
cal risk, but also to monitor progress towards optimized lev-
els of well-being for a given individual. Routine monitoring
of physical function and sharing this information with the
people concerned can also be used to motivate patients
to actively engage with PA to maintain/enhance physical
function [24]
What tests?
One of the gaps in the process of translating the general public
PA activity guidelines as well as the CKD-specific guidelines [21,
22] into routine clinical practice is the lack of systematic
recording and monitoring of PA and physical function attributes
that can be used to develop individualized and measurable
plans of action to promote PA for health. Clinical guidelines
state that all CKD patients should have at least one session with
a health professional to assess physical function and to advise
on health-enhancing PA. Given the evidence that inactivity,
physical dysfunction and physical frailty are prevalent and se-
vere, we suggest that all CKD Stages 3b–5 patients should have
at least one session with an exercise/rehabilitation specialist to
assess PA behaviour, physical function and readiness to change
PA behaviour, with the aim that all patients receive written ad-
vice and specific goals/targets and exercise prescription or refer-
ral and information about local PA/exercise opportunities that
they can self-manage and that outcomes should be docu-
mented on medical records for monitoring purposes (Figure 1).
The choice of assessment tools will largely be determined
by the individual’s overall health status and willingness to col-
laborate, staff expertise and equipment availability. It is also
important to note that for some patients, functional capacity
assessment and especially determination of peak exercise
capacity may be contraindicated [24, 27]. Furthermore, the
choice of the type and specific protocol for physical function as-
sessment should be based on the primary purpose of the as-
sessment (diagnostic, exercise training prescription and risk
stratification) and should also take into consideration the
FIGURE 1: Proposed steps for the implementation of physical function assessment in clinical practice.
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minimum standards of clinimetric utility (published validity, re-
liability and ideally responsiveness where data available) and
normative data.
Summary information, extracted from the research and
practice literature, about the different types of physical function
tests indicated for use in clinical practice with CKD patients is
provided in Table 2.
THE EFFECTS OF EXERCISE TRAINING ON
HRQOL IN PATIENTS WITH CKD
HRQoL is a multidimensional concept that includes several
domains focused on physical, mental, emotional and social
functioning and reflects the impact of health status on individ-
ual well-being. Several studies have shown that CKD per se
affects patients’ HRQoL, as there is an association between the
severity of CKD and the self-reported HRQoL [37]. On the other
hand, low HRQoL was found to be associated with clinical out-
comes, frequent hospitalization and decreased survival in dialy-
sis patients [38]. Van Loon et al. [39] showed that HRQoL is an
indicator of poor outcome in HD patients, as sedentary lifestyle,
low HRQoL and reduced VO2max were associated with in-
creased mortality risk among HD patients. Thus HRQoL is con-
sidered an important outcome in CKD and, according to the
Kidney Disease Outcomes Quality Initiative clinical practice
guidelines 2002, is recommended to be repeatedly measured in
clinical practice [40]. The tools used for HRQoL assessment and
its determinants can either be generic or disease specific. They
can be self- or interviewer administered. In clinical practice, the
combination of multiple instruments may provide more reliable
results. Studies that focus on the assessment of HRQoL in CKD
patients have most frequently used the SF-36 and the Kidney
Disease Quality of Life Short Form as instruments, since they
are well-validated measures of general health and physical
functioning and are translated into many languages [41–48]
(Table 3).
HRQOL was found to be a significant independent risk factor
for CKD progression [49]. In dialysis patients, renal replacement
therapies in combination with the presence of other chronic
diseases, such as cardiovascular diseases and diabetes, malnu-
trition and sarcopaenia, frailty or disability, pain/discomfort
and low physical functioning are known factors that have a neg-
ative impact on HRQoL [49, 50]. Moreover, depression and anxi-
ety are found to be associated with poor HRQoL [51].
Additionally, a sedentary lifestyle and the lack of PA affect thhe
patient’s biopsychosocial health and independence and are as-
sociated with lower levels of physical functioning and physical
domains of HRQoL [39].
Exercise rehabilitation programmes are focused on improv-
ing each patient’s physical and psychosocial functioning to
their optimal level. Research reports from the early 1980s
through 2000 clearly showed that an outpatient aerobic exercise
training programme lasting from 16 to 24 weeks can decrease
anxiety and depression and improve physical function and the
burden of disease and thus enhance overall HRQoL results [52].
An outpatient exercise training programme is an effective way
to improve the quality of social interaction since patients exer-
cise in groups. Later on, intradialytic exercise training pro-
grammes gained ground as a more convenient and flexible way
of training that increases compliance with the exercise pro-
gramme. Several meta-analyses of RCTs concluded that an
intradialytic exercise programme lasting from 8 to 48 weeks can
improve HD adequacy, exercise capacity and the physical
domain of HRQoL [53]. However, after intradialytic exercise
training, no improvement was noted in the SF-36 mental com-
ponent summary level [53]. The exercise regimens differed
widely between the studies in terms of exercise type, intensity,
frequency and duration.
The majority of the studies that have examined the effects
of intradialytic exercise training on HRQoL have used an aerobic
programme at a moderate intensity. There is a discrepancy in
the results from a resistance exercise training programme dur-
ing HD on HRQoL. Although Segura-Ortı́ et al. [54] reported that
resistance intradialytic training did not affect HRQoL, there is
evidence that a combination of resistance training plus oral
supplementation can improve some aspects of HRQoL, such as
self-reported physical functioning [55] and general health per-
ceptions and social function [56]. On the other hand, interven-
tions that included both intradialytic aerobic and resistance
exercises reported favourable physical HRQoL changes [25].
The important role of PA in improving HRQoL in CKD
patients is well recognized [57]. A 6-month home-based, low-in-
tensity exercise programme was found to improve several
domains of HRQoL in HD patients, and specifically cognitive
function and quality of social interaction [58]. Similarly, a 12-
week home-based either aerobic or mixed-type exercise pro-
gramme resulted in improvements of several domains of
HRQoL exclusively in PD patients [59].
Several factors contribute to the improvement of HRQoL
domains after exercise training in CKD patients (Figure 2).
Several studies have found a positive strong correlation be-
tween improvements in aerobic capacity and HRQoL scores [59–
61]. Exercise training can reverse fatigue, frailty and disability in
CKD. The favourable effects of exercise training on functional
performances such as endurance, gait, postural control and
muscular strength can increase patients’ mobility, vitality and
physical domains of HRQoL. That makes them more indepen-
dent and able to participate in several ADL, increasing their so-
cialization and life satisfaction [52]. A Cochrane systematic
review also revealed significant improvements in physical fit-
ness, muscular functioning, walking capacity, cardiovascular
function and HRQoL in HD patients, especially after aerobic ex-
ercise programmes [62].
Also, a recent meta-analysis showed that exercise interven-
tions can improve the mood disorders that might be triggered
by a reduction in physical function, especially depression and
anxiety in CKD patients [51]. Similarly, a 1-year intradialytic ex-
ercise training programme was found to be effective in improv-
ing the functional limitations, cardiac autonomic dysfunction
and psychological distress that are known disorders in HD
patients [63].
Quality of sleep is another significant parameter that affects
patient’s HRQoL and can be improved by exercise training.
Corrêa et al. [64] showed that a 3-month intradialytic resistance
training programme can improve the clinical status of HD
patients by improving their sleep quality, oxidative and inflam-
matory parameters. This is in line with previous reports that ex-
ercise training can improve stress and inflammation
biomarkers in patients with CKD [65].
Educating patients about the benefits of regular exercise will
help them better manage the discomfort they face in everyday
life and obtain a near-normal life.
CONCLUSION
Adequate and varied PA participation is a prerequisite for ade-
quate physical function for normal life participation, perceived
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satisfaction and general feelings of well-being. Maintenance of
functional independence and prevention of disability is a prior-
ity in all clinical practice guidelines for the management of peo-
ple in all stages of CKD. Exercise-based therapies are effective in
restoring and further improving physical function, and
subsequently HRQoL. We propose that PA and physical
function should be routinely assessed and monitored in the
CKD population and we have suggested a range of tools for
their assessment as currently supported by research and
practice-based evidence. Further research is required to
Table 2. Selection of evidence-based physical function outcome measures for use in people in all stages of CKD for routine physical function
assessment
Physical function domain Measurement outcomes
End-points
(when to terminate
physical function testing) Comments
Physiological impairment




No increases in BP with increas-
ing workload
BP>220/110 mmHg
Symptoms such as dizziness, an-
gina, lack of responsiveness to
oral and/or visual signs
Patient’s request
Equipment failure
Familiarization session should be
provided
Reproducibility information available [28]
Absolute dynamic
muscle strength
Maximum weight lifted in a
continuous fashion; once, 1
maximum repetition




Inability to continue due to ad-
verse symptom development
Familiarization sessions may be required
Whole body and muscle group–specific
warm-up sessions are required
Muscle function–related measures are
strong independent predictors of
disease progress and survival
Reproducibility information available [28]
Normative data and cut-off criteria avail-
able [28, 29]
Cut-off points for Frailty phenotype [29]
Cut-off points for sarcopaenia [30]
Relative dynamic
muscle strength
Maximum number of repeti-
tions
performed as a percent of
RM





Walking distance (m) Patient’s request
Inability to continue due to ad-
verse symptom development
Reproducibility information available [29]
Familiarization sessions may be required
Assessor and patient friendly
Quick and inexpensive
Minimum interference and inconve-
nience for patient










Sit-to-stand tests Time (s) it takes to complete 5
(STS-5) or 10 (STS-10)
complete STS transfers
or
STS-60 (total number of
complete STS transfers
achieved in 60 s)
Disability (ADL)
PCS from SF-36 or
from KDQOL
PCS (0–100) Composite score made up of a range of
perceived physical abilities for ADL
and symptoms
KDQOL also reports on a range of symp-




Widely used in the CKD population
DASI index [33] Total score from 0 to 58.2 All widely used in various chronic
conditions and limited DASI- and
KATZ-based data exist in CKD




Total score from 0 to 15
Katz index [35] Total score from 0 to 6
Barthel index [36] Total score from 0 to 100 or in
modified version 0–20
BP, blood pressure; HR, heart rate; RPE, ratings of perceived exertion; DASI: Duke Activity Status Index.
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establish cut-off points for the minimum amount of PA and
the physical function level that anchor different risk classifi-
cations for broader health outcomes such as mortality, opti-
mal HRQoL and disability.
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